logo

Scholar Rock Holding Corp (SRRK)



Trade SRRK now with
  Date
  Headline
6/18/2021 8:07:41 AM Scholar Rock To Present Apitegromab TOPAZ Phase 2 Trial Results At 2021 European Academy Of Neurology Congress
6/7/2021 7:57:19 AM Scholar Rock To Present Apitegromab Clinical Data From TOPAZ Phase 2 Trial In Type 2 & 3 Spinal Muscular Atrophy At SMA
5/13/2021 7:45:21 AM Scholar Rock Q1 Loss Per Share $0.76 Vs Loss Per Share $0.58 Prior Year
4/6/2021 7:09:17 AM Scholar Rock Announces Positive 12-Month Top-Line Results From The TOPAZ Phase 2 Clinical Trial
1/27/2021 8:07:36 AM Scholar Rock Presents Preclinical Data For SRK-181 At TGF For Immuno-Oncology Drug Development Summit
11/9/2020 8:23:14 AM Scholar Rock Q3 Net Loss $23.6 Mln Vs. Net Loss $16.1 Mln Last Year
10/28/2020 11:27:20 PM Scholar Rock Holding Prices Underwritten Public Offering Of 2.95 Mln At $39.00/shr
8/7/2020 7:28:13 AM Scholar Rock Q2 Net Loss $19.3 Mln Or $0.65/Shr Vs Loss Of $12.5 Mln Or $0.48/Shr Last Year
7/16/2020 7:35:24 AM Scholar Rock Appoints Edward Myles As CFO And Head Of Business Operations
7/14/2020 7:33:35 AM Scholar Rock Appoints Tony Kingsley As President And CEO
5/15/2019 7:43:09 AM Wedbush Is Increasing Scholar Rock Holding Corp (SRRK) FY19 Estimate To -1.64 From -1.85
5/15/2019 7:42:56 AM Wedbush Is Increasing Scholar Rock Holding Corp (SRRK) Q4 19 Estimate To -0.40 From -0.46
5/15/2019 7:42:44 AM Wedbush Is Increasing Scholar Rock Holding Corp (SRRK) Q3 19 Estimate To -0.42 From -0.49